Spotlight: Mar 31, 2026
Researchers are developing an implantable device containing insulin-producing cells, to replace regular injections for type 1 diabetes. The goal is “a device that could continuously create protein therapeutics on demand and as needed by the patient,” Daniel Anderson says.